ArticleBMC genomics2026
CMC-WDTK: CpG methylation change prediction by a weight-sharing dual-branch Transformer-Kolmogorov-Arnold network model.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Differential methylation is a key epigenetic process contributing to cancer development. Most DNA methylation prediction methods rely on DNA sequences from the background reference genome, neglecting individual genetic variation, which limits their ability to capture methylation differences. To address this, we propose CMC-WDTK, a deep learning framework that combines a weight-sharing dual-branch Transformer with a Kolmogorov‒Arnold network (KAN) to integrate sequences flanking CpG sites and adjacent single nucleotide variation (SNV) information to predict methylation changes between DNA sequences. CMC-WDTK captures global and local features of both reference and variant sequences and models high-dimensional relationships, offering accurate predictions of methylation changes. CMC-WDTK accurately predicted DNA methylation changes in eight real datasets (AUC greater than 0.8 for all datasets), with strong generalizability across datasets. Method comparison and ablation analyses further confirm that CMC-WDTK outperforms existing approaches and that its full architectural design is essential for achieving robust and accurate methylation-change prediction across datasets. Additionally, it identified a repeated cytosine and guanine sequence motif that promotes increased methylation. CMC-WDTK is the first computational tool used to predict methylation changes between sequences, offering significant advancements in understanding and comparing DNA methylation across diverse datasets and biological conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.